FRINK Linked Data Fragments server

Matches in Wikidata for { <http://www.wikidata.org/entity/Q37638982> ?p ?o ?g. }

• Q37638982 description "article científic" @default.
• Q37638982 description "article scientifique" @default.
• Q37638982 description "articolo scientifico" @default.
• Q37638982 description "artigo científico" @default.
• Q37638982 description "artículu científicu espublizáu en 2017" @default.
• Q37638982 description "bilimsel makale" @default.
• Q37638982 description "scientific article published on 13 February 2017" @default.
• Q37638982 description "vedecký článok" @default.
• Q37638982 description "vetenskaplig artikel" @default.
• Q37638982 description "videnskabelig artikel" @default.
• Q37638982 description "vědecký článek" @default.
• Q37638982 description "wetenschappelijk artikel" @default.
• Q37638982 description "wissenschaftlicher Artikel" @default.
• Q37638982 description "наукова стаття, опублікована в лютому 2017" @default.
• Q37638982 description "научни чланак" @default.
• Q37638982 description "مقالة علمية نشرت في 13 فبراير 2017" @default.
• Q37638982 name "Aberrant corticosteroid metabolism in tumor cells enables GR takeover in enzalutamide resistant prostate cancer." @default.
• Q37638982 name "Aberrant corticosteroid metabolism in tumor cells enables GR takeover in enzalutamide resistant prostate cancer." @default.
• Q37638982 name "Aberrant corticosteroid metabolism in tumor cells enables GR takeover in enzalutamide resistant prostate cancer." @default.
• Q37638982 type Item @default.
• Q37638982 label "Aberrant corticosteroid metabolism in tumor cells enables GR takeover in enzalutamide resistant prostate cancer." @default.
• Q37638982 label "Aberrant corticosteroid metabolism in tumor cells enables GR takeover in enzalutamide resistant prostate cancer." @default.
• Q37638982 label "Aberrant corticosteroid metabolism in tumor cells enables GR takeover in enzalutamide resistant prostate cancer." @default.
• Q37638982 prefLabel "Aberrant corticosteroid metabolism in tumor cells enables GR takeover in enzalutamide resistant prostate cancer." @default.
• Q37638982 prefLabel "Aberrant corticosteroid metabolism in tumor cells enables GR takeover in enzalutamide resistant prostate cancer." @default.
• Q37638982 prefLabel "Aberrant corticosteroid metabolism in tumor cells enables GR takeover in enzalutamide resistant prostate cancer." @default.
• Q37638982 P1433 Q37638982-B9990421-2DA2-4D54-955E-5AD66AA19A2F @default.
• Q37638982 P1476 Q37638982-E25FB368-F39D-4CED-9015-EA28D98170D4 @default.
• Q37638982 P2093 Q37638982-16E46A7F-A16B-420D-8701-A3073474E2AF @default.
• Q37638982 P2093 Q37638982-21DDA279-B8A9-4C58-B976-4F3781F7A024 @default.
• Q37638982 P2093 Q37638982-480C688C-1F24-48EB-9362-3820AC515BAA @default.
• Q37638982 P2093 Q37638982-505353F6-9577-4BC7-BF4A-53798D300D17 @default.
• Q37638982 P2093 Q37638982-673A453C-3299-41EF-BD21-4846F24D77E3 @default.
• Q37638982 P2093 Q37638982-751EBB6B-E58B-4633-A705-29E6BF01C66F @default.
• Q37638982 P2093 Q37638982-8A6F5E54-E288-4410-AA11-FC77168AFE42 @default.
• Q37638982 P2093 Q37638982-A5097EA8-F1D9-4F45-A3A3-74C3006FD025 @default.
• Q37638982 P2093 Q37638982-C07765E2-D000-44ED-82A2-34527F17EDE9 @default.
• Q37638982 P2093 Q37638982-CA63F923-DC2C-4BEA-B280-D2842122EA67 @default.
• Q37638982 P2093 Q37638982-D8FE25F4-AE78-4741-8AAA-3432CB8796C1 @default.
• Q37638982 P2860 Q37638982-046AF83B-EDA3-4E3D-8F81-A90C01DAD00D @default.
• Q37638982 P2860 Q37638982-1952E38C-1E71-44E7-8685-1E8A276AE325 @default.
• Q37638982 P2860 Q37638982-1A4861CB-7453-43ED-800F-D9F660C1FCA3 @default.
• Q37638982 P2860 Q37638982-21282CAF-D1CE-4A9A-BF2A-D853F0374466 @default.
• Q37638982 P2860 Q37638982-2441560E-5B7C-44CF-99A8-3582ADA5977A @default.
• Q37638982 P2860 Q37638982-24B3C04C-1FD0-4EBA-8C7F-90062E4818D2 @default.
• Q37638982 P2860 Q37638982-2B70D512-E7F7-4A46-A8C2-E4B9DACE92B9 @default.
• Q37638982 P2860 Q37638982-37DA72C5-4BBA-40C9-B0DD-A2A1B0AB5044 @default.
• Q37638982 P2860 Q37638982-3967FD6F-BD81-4416-9217-FBDB2E54987F @default.
• Q37638982 P2860 Q37638982-4181F28B-EA70-4F8C-A5DF-31620BE89BAC @default.
• Q37638982 P2860 Q37638982-423B678E-91AB-4453-B9A0-4A6B92F656C7 @default.
• Q37638982 P2860 Q37638982-461A4A76-8517-429B-8DE0-25F3D628062D @default.
• Q37638982 P2860 Q37638982-4FCA5FF1-DAF7-4CF8-9578-11AE3EC6155A @default.
• Q37638982 P2860 Q37638982-50A87649-8494-4F58-B60C-B22D2ED52C7D @default.
• Q37638982 P2860 Q37638982-5254EC98-0F47-4CEA-B60F-D2B2D90E0153 @default.
• Q37638982 P2860 Q37638982-61E2F8A2-8BA3-4E73-B1EF-7302177F79B5 @default.
• Q37638982 P2860 Q37638982-684638DE-1CE2-437C-88B1-2594C9B653E3 @default.
• Q37638982 P2860 Q37638982-81129B75-92D4-493B-9412-2EF6E290766B @default.
• Q37638982 P2860 Q37638982-89A973DB-7948-44F0-97B9-E34072ACBBA9 @default.
• Q37638982 P2860 Q37638982-98FDDAB5-A017-4875-BBF6-B82CF9F248B9 @default.
• Q37638982 P2860 Q37638982-9D16235A-D4FB-44BD-9435-F47154EE29A8 @default.
• Q37638982 P2860 Q37638982-AF962FED-E8AC-46B8-8EA6-AE570E229C84 @default.
• Q37638982 P2860 Q37638982-B2329BDC-C524-41B9-9120-43F3149408AC @default.
• Q37638982 P2860 Q37638982-CCB62EA7-D522-4AFA-A793-046680A99E10 @default.
• Q37638982 P2860 Q37638982-D09FFD2B-74E7-4726-B283-08BF6D87F001 @default.
• Q37638982 P2860 Q37638982-E767E936-BF53-4D2D-98CC-8B855391940F @default.
• Q37638982 P2860 Q37638982-EA1296D7-BA6E-43C7-943A-0334581786CC @default.
• Q37638982 P31 Q37638982-C6369ECC-524B-4C80-854C-668C304D8B23 @default.
• Q37638982 P356 Q37638982-0E276973-A80C-4925-B55F-84D652E7BCD6 @default.
• Q37638982 P407 Q37638982-72333F63-E045-458A-8023-FB831B6ADC21 @default.
• Q37638982 P478 Q37638982-A9F67382-F5A8-45FD-82D3-999738D9746B @default.
• Q37638982 P50 Q37638982-3D570525-B6C9-4356-BF1E-D030C75BA1FA @default.
• Q37638982 P50 Q37638982-73600D75-A92B-4AA4-A603-7FCF1DB41E52 @default.
• Q37638982 P50 Q37638982-7A0F3E51-F6F0-421B-A136-50BEE11A4BD1 @default.
• Q37638982 P577 Q37638982-D7B6912C-D001-4749-8B6F-6C383DC529E3 @default.
• Q37638982 P698 Q37638982-640DE8C8-AC7D-4803-A6A3-781D7C7C2737 @default.
• Q37638982 P921 Q37638982-B9D8B785-0579-42C7-8ECD-6737E7666447 @default.
• Q37638982 P932 Q37638982-399492B4-7B62-49E6-9DE1-5500817ECE2B @default.
• Q37638982 P356 ELIFE.20183 @default.
• Q37638982 P698 28191869 @default.
• Q37638982 P1433 Q2000008 @default.
• Q37638982 P1476 "Aberrant corticosteroid metabolism in tumor cells enables GR takeover in enzalutamide resistant prostate cancer" @default.
• Q37638982 P2093 "Ao Zhang" @default.
• Q37638982 P2093 "Cristina Magi-Galluzzi" @default.
• Q37638982 P2093 "Eric A Klein" @default.
• Q37638982 P2093 "Jianneng Li" @default.
• Q37638982 P2093 "Jorge A Garcia" @default.
• Q37638982 P2093 "Kai-Hsiung Chang" @default.
• Q37638982 P2093 "Kevin Courtney" @default.
• Q37638982 P2093 "Mary-Ellen Taplin" @default.
• Q37638982 P2093 "Michael Berk" @default.
• Q37638982 P2093 "Mohammad Alyamani" @default.
• Q37638982 P2093 "Zhenfei Li" @default.
• Q37638982 P2860 Q24296860 @default.
• Q37638982 P2860 Q24312457 @default.
• Q37638982 P2860 Q24339552 @default.
• Q37638982 P2860 Q24605577 @default.
• Q37638982 P2860 Q24613957 @default.
• Q37638982 P2860 Q29617511 @default.
• Q37638982 P2860 Q33621387 @default.
• Q37638982 P2860 Q33823702 @default.

• next